期刊文献+

Synthesis and pharmacological properties of naturally occurring prenylated and pyranochalcones as potent anti-inflammatory agents 被引量:5

Synthesis and pharmacological properties of naturally occurring prenylated and pyranochalcones as potent anti-inflammatory agents
原文传递
导出
摘要 An efficient approach has been developed for the synthesis of naturally occurring prenylated chalcones viz. kanzonol C (1), stipulin (2), crotaorixin (3), medicagenin (4), licoagrochalcone A (5) and abyssinone D (6) along with the pyranochalcones paratocarpin C (7), anthyllisone (8) and 3-O-methylabyssinone A (9). The key step of the synthesis is a Claisen-Schmidt condensation. Subsequently, their anti-inflammatory effects were investigated in lipopolysaccharides (LPSs)-induced RAW-264.7 macrophages. Of the synthesized chalcones, compounds 5 (IC50= 10.41 μmol[L), 6 (IC50= 9.65 μmol/L) and 8 (IC50= 15.34 μmol/L) show remarkable activity with no cytotoxicity. Compound 9 (IC50 = 4.5 μmol/L) exhibits maximum (83.6%) nitric oxide (NO) inhibition, but shows slight cytotoxicity. The results reveal that the chalcones bearing the prenyl group at 3- and/or 5-position on ring A (acetophenone moiety), i.e., 1-4 and 7 show weak, or no inhibition activity, whereas chalcones having the prenyl group only on ring B (aldehyde part), i.e., 5, 6 and 8 show significant activity on the production of inflammatory mediated NO with no cytotoxicity. An efficient approach has been developed for the synthesis of naturally occurring prenylated chalcones viz. kanzonol C (1), stipulin (2), crotaorixin (3), medicagenin (4), licoagrochalcone A (5) and abyssinone D (6) along with the pyranochalcones paratocarpin C (7), anthyllisone (8) and 3-O-methylabyssinone A (9). The key step of the synthesis is a Claisen-Schmidt condensation. Subsequently, their anti-inflammatory effects were investigated in lipopolysaccharides (LPSs)-induced RAW-264.7 macrophages. Of the synthesized chalcones, compounds 5 (IC50= 10.41 μmol[L), 6 (IC50= 9.65 μmol/L) and 8 (IC50= 15.34 μmol/L) show remarkable activity with no cytotoxicity. Compound 9 (IC50 = 4.5 μmol/L) exhibits maximum (83.6%) nitric oxide (NO) inhibition, but shows slight cytotoxicity. The results reveal that the chalcones bearing the prenyl group at 3- and/or 5-position on ring A (acetophenone moiety), i.e., 1-4 and 7 show weak, or no inhibition activity, whereas chalcones having the prenyl group only on ring B (aldehyde part), i.e., 5, 6 and 8 show significant activity on the production of inflammatory mediated NO with no cytotoxicity.
出处 《Chinese Chemical Letters》 SCIE CAS CSCD 2016年第5期698-702,共5页 中国化学快报(英文版)
基金 financially supported by Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (No. NRF-2009-0094071), South Korea
关键词 Prenylated chalcone Pyranochalcone Claisen-Schmidt condensation Anti-inflammatory Nitric oxide (NO) Prenylated chalcone Pyranochalcone Claisen-Schmidt condensation Anti-inflammatory Nitric oxide (NO)
  • 相关文献

参考文献35

  • 1J. Quintans, Immunity and inflammation: the cosmic view, lmmunol. Cell Biol. 72 (1994) 262-264.
  • 2S. Moncada, R.M. Palmer, E.A. Higgs, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol. Rev. 43 (1991) 109-142.
  • 3B. Hinz, K. Brune, Cyclooxygenase-2-10 years later, J. PharmacoL Exp. Ther. 300 (2002) 367-375.
  • 4D.L Batovska, J.T. Todorova, Trends in utilization of the pharmacological potential of chalcones. Curr. Clin. Pbarmcol. 5 (2010) 1-29.
  • 5A.K. Singh, G. Saxena, R. Prasad, A. Kumar, Synthesis, characterization and calculated non-linear optical properties of two new chalcones,J. Mol. Struct. 1017 (2012) 26-31;.
  • 6(b) E.D. D'silva, G.K. Podagatlapalli, S.V. Rao, et al., New, high efficiency nonlinear optical chalcone co-crystal and structure-property relationship, Cryst. Growth.
  • 7s.J. Won, C.T. Liu, L.T. Tsao, et al., Synthetic chalcones as potential anti-inflamma- tory and cancer chemopreventive agents, Eur. J. Med. Chem. 40 (2005) 103-112.
  • 8J.F. Stevens, C.L. Miranda, B. Frei, D.R. Buhler, Inhibition of peroxynitrite-mediated LDL oxidation by prenylated flavonoids: the α,β-unsaturated keto functionality of 2'-hydroxychalcones as a novel antioxidant pharmacophore, Chem. Res. Toxicol. 16 (2003) 1277-1286.
  • 9F. Lunardi, M. Guzela, A.T. Rodrigues, et al., Trypanocidal and leishmanicidal properties of substitution containing chalcones, Antimicrob. Agents Chemother. 47 (2003) 1449-1451.
  • 10M. Ritter, R.M. Martins, D. Dias, M.P. Pereira, Recent advances on the synthesis of chalcones with antimicrobial activities: a brief review, Lett. Org. Chem. 11 (2014) 498-508.

同被引文献19

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部